how many people use glp-1 drugs trends 2025: real-world data, patient outcomes & future therapies Ozempic Statistics: GLP-1 Weight Loss
Description
Scope exclusions include bariatric devices, dietary supplements, wellness apps, and compounded medications, which are outside our remit
Key Report Takeaways By mechanism of action, GLP-1 receptor agonists led with 38.55% of the anti-obesity drugs market share in 2025
Chronic Disease Prevalence : Rising global rates of type 2 diabetes and obesity are expanding the patient pool for GLP1 therapies, increasing demand for both glycemic and weight management indications
doi: 10.1111/dom.13764
Whilst declining beta-cell function is thought to generally reduce the response to incretins, GLP-1 appeared to be the more important incretin hormone in T2D (Nauck et al, 2021)
At TrimRx, we offer quick-access supplements like GLP-1 Daily Support and Weight Loss Boost
